Skip to main content

IDNA

ETF
—
—

Performance overview

IDNA Price
Price Chart

Forward-looking statistics

Beta
0.79
Risk
21.98%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.

Fund info

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.

Investing methodPassively Managed
DiversifiedNo
Expense ratio0.47%
Asset classUnknown

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)—
Dividend per share$0.22
Revenue per share—
Avg trading volume (30 day)$507K
Avg trading volume (10 day)$407K
Put-call ratioN/A

Macro factor sensitivity

Growth-0.4
Credit+3.6
Liquidity-0.4
Inflation-2.9
Commodities+0.2
Interest Rates-1.6

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayDecember 17, 2024

News

Will 2023 be the Year of Cathie Wood ETFs?

Cathie Wood, famous for the success of Ark Investment???s winning products, had faced a miserable fate in 2022.

Zacks Investment Research (January 24, 2023)
3 ETFs For More Moderna Bets

Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.

Benzinga (May 19, 2020)
ETF Edge: Big boost for energy ETF

CNBC's Bob Pisani breaks down the biggest exchange-traded funds moves.

CNBC Television (May 18, 2020)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free